Eun Joo Chung

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
    HanByoul Cho
    Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, 146 92 Dogok dong, Gangnam Gu, Seoul 135 720, South Korea
    BMC Cancer 14:545. 2014
  2. pmc Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies
    Deborah E Citrin
    Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Radiat Oncol 7:64. 2012
  3. pmc Evaluation of the fullerene compound DF-1 as a radiation protector
    Aaron P Brown
    Radiation Oncology Branch, National Cancer Institute, Building 10 CRC B2 3500, Bethesda, MD 20892, USA
    Radiat Oncol 5:34. 2010

Detail Information

Publications3

  1. pmc Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
    HanByoul Cho
    Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, 146 92 Dogok dong, Gangnam Gu, Seoul 135 720, South Korea
    BMC Cancer 14:545. 2014
    ..Here, we investigated API5 expression in cervical cancer, its clinical significance, and its relationship with phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2) in development and progression of cervical cancer...
  2. pmc Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies
    Deborah E Citrin
    Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Radiat Oncol 7:64. 2012
    ..The purpose of this pilot study was to determine the feasibility of measuring local salivary cytokine levels using buccal sponges in patients receiving chemo-radiation for head and neck malignancies...
  3. pmc Evaluation of the fullerene compound DF-1 as a radiation protector
    Aaron P Brown
    Radiation Oncology Branch, National Cancer Institute, Building 10 CRC B2 3500, Bethesda, MD 20892, USA
    Radiat Oncol 5:34. 2010
    ..The purpose of this study was to evaluate the radioprotective effects of DF-1 in a murine model of lethal total body irradiation and to assess for selective radioprotection of normal cells versus tumor cells...